Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_assertion description "[In gene expression profiling, the antiapoptotic protein survivin (BIRC5) demonstrated a striking increase in ATL, and its expression was increased in patient ATL cells resistant to the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_assertion evidence source_evidence_literature NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_assertion SIO_000772 23321252 NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_assertion wasDerivedFrom befree-2016 NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_assertion wasGeneratedBy ECO_0000203 NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.
- befree-2016 importedOn "2016-02-19" NP1044093.RAI8G2ocf3zQxpNNIhOWJEjOKCd2VNDEsj7S9ygNJyW3U130_provenance.